At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.
We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.
What You’ll Do:
The Associate Director, Bioanalytical Sciences at Kailera Therapeutics will report to the Director, Bioanalytical Sciences and will be responsible for designing and executing bioanalytical strategies to support development programs for patients with obesity-related diseases. This role will oversee GLP-compliant bioanalytical work for non-clinical and clinical studies. The Associate Director will manage CRO-outsourced bioanalysis to advance drug candidates through various development stages while partnering with cross-functional teams to ensure the seamless integration of data into Kailera’s broader development programs.
Required location: Waltham, MA (hub-based, onsite 3-4 days per week)
Responsibilities:
- Lead bioanalytical strategy and execution in clinical and non-clinical studies
- Collaborate with cross-functional teams to design and implement bioanalytical aspects of clinical development programs
- Identify, select, and oversee CROs, ensuring adherence to timelines, budgets, and regulatory requirements
- Manage and oversee outsourced bioanalysis of small molecules, peptides, and biomarkers
- Direct the development, validation, and implementation of bioanalytical assays
- Review validation protocols, test procedures, raw data, and technical reports to ensure scientific rigor and compliance with regulatory guidelines
- Provide leadership in ensuring GLP compliance for bioanalysis in both non-clinical and clinical trials
- Author and review bioanalytical sections of regulatory submissions
- Represent the bioanalytical function in cross-functional project teams
Required Qualifications:
- 10+ years of relevant industry experience in bioanalytical sciences with a Bachelor’s degree or 5+ years with an advanced degree
- Expertise in regulated bioanalysis and clinical-stage drug development
- In-depth knowledge of GLP/GCP requirements and industry best practices in bioanalytical laboratories
- Proven experience in the regulatory requirements for method development and validation
- Strong track record of managing CRO-outsourced bioanalysis and vendor relationships
- Excellent project management skills with the ability to manage multiple priorities effectively
- Experience with regulatory interactions is highly desirable
- Experience contributing to regulatory filings for biologics and small molecules
Preferred Qualifications:
- Experience with GLP-1 receptor agonists or related therapeutic areas
- Strong understanding of bioanalytical considerations for incretin-based therapies
Education:
- Bachelor's degree in a relevant scientific discipline required (e.g., bioanalytical chemistry, pharmacology, or related field); PhD preferred
For Full Time Roles: This range represents the company’s good-faith estimate of the salary at the time of posting. Actual pay may vary based on experience, skills, qualifications, location, and internal equity. We also offer comprehensive health coverage, flexible time off, paid holidays, and a year-end shutdown. Enjoy a monthly wellness stipend, generous 401(k) match, tuition reimbursement, commuter benefits, disability and life insurance, plus annual bonus opportunities and equity grants—because your well-being and future matter to us.
EQUAL EMPLOYMENT OPPORTUNITY INFORMATION:
Kailera Therapeutics, Inc. is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race (including traits historically associated with race, such as hair texture and protective hairstyles), color, creed, religion (including religious dress and grooming practices), national origin, ancestry, citizenship status, age (40 and over), sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, reproductive health decisions, domestic victim status, political affiliation, or any other characteristic protected by applicable federal, state, or local laws and ordinances.
E-Verify:
Kailera Therapeutics, Inc. uses E-Verify to confirm the identity and employment eligibility of all new hires.
#LI-Hybrid
Skills Required
- 10+ years of relevant industry experience in bioanalytical sciences with a bachelor's degree, or 5+ years with an advanced degree
- Bachelor's degree in a relevant scientific discipline such as bioanalytical chemistry, pharmacology, or a related field
- Expertise in regulated bioanalysis and clinical-stage drug development
- In-depth knowledge of GLP/GCP requirements and bioanalytical laboratory best practices
- Experience with regulatory requirements for method development and validation
- Experience managing CRO-outsourced bioanalysis and vendor relationships
- Strong project management skills and ability to manage multiple priorities
- Experience contributing to regulatory filings for biologics and small molecules
- Experience with regulatory interactions
- Experience with GLP-1 receptor agonists or related therapeutic areas
- Strong understanding of bioanalytical considerations for incretin-based therapies
- PhD in a relevant scientific discipline
What We Do
Kailera is an advanced clinical-stage biotechnology company focused on obesity care. It is developing a diversified pipeline of GLP-1 therapies and other obesity-management medications intended to provide treatment options for people living with obesity across their treatment journeys. The company’s team has experience developing and commercializing therapies for metabolic diseases, and its clinical-stage candidates use multiple GLP-1 mechanisms and routes of administration.
